Psychologists in Gaylord, MI Accepting Medicare
7 Psychologists found. Showing 1 - 7
 Kyle Scott Psychologist Medicare: Not Enrolled in Medicare Practice Location: 128 N Court Ave, Gaylord, MI 49735 Phone: 989-448-8344 |
 Mary Margaret Bachman-moran, MA,LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Livingston Blvd Ste B, Gaylord, MI 49735 Phone: 989-732-6292 Fax: 989-732-0780 |
Dr. John Paul Jones, PH.D. Psychologist - Cognitive & Behavioral Medicare: Accepting Medicare Assignments Practice Location: 606 N Court Ave, Gaylord, MI 49735 Phone: 989-732-6488 Fax: 989-732-2551 |
Robert J Latka, MA,LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Livingston Blvd Ste B, Gaylord, MI 49735 Phone: 989-732-6292 Fax: 989-732-0780 |
Ms. Pamela Anne Mcmillan, M.A., ED. SPEC. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 128 N Court Ave, Gaylord, MI 49735 Phone: 989-448-2328 Fax: 231-941-8981 |
Jeanette Sayre Psychologist Medicare: Not Enrolled in Medicare Practice Location: 711 S Illinois Ave, Gaylord, MI 49735 Phone: 989-732-4357 |
Andrea J Sarto, LLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Livingston Blvd Ste A, Gaylord, MI 49735 Phone: 989-732-6292 Fax: 989-732-0780 |
News Archive
FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels
Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.
Research findings could lead to development of improved breast cancer drugs
Biomedical scientists have revealed the inner workings of a group of proteins that help to switch critical genes on and off during blood-cell production, in a finding that could lead to the development of new and improved cancer drugs.
Pfizer receives positive opinion from EMA CHMP for crizotinib to treat ALK-positive NSCLC
Pfizer announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that crizotinib be granted conditional marketing authorization in the European Union (EU), for the treatment of adults with previously treated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).
Galderma's trifarotene molecule gets FDA Orphan Drug Designation for treatment of congenital ichthyosis
Galderma announces that the U.S. FDA granted Orphan Drug Designation status for the company's trifarotene molecule for the treatment of congenital ichthyosis. Based on this decision, Galderma plans to implement a clinical development plan, reinforcing its commitment to exploring new treatment options for rare diseases, as well as meeting the needs of all patients with skin diseases over the course of their lives.
Tiny molecule might help protect pancreas from cancer
A tiny molecule might help protect the pancreas from deadly disease and cancer. Tackling a mysterious process: There is a feeling that neglected cancers need more research and Pancreatic cancer is one of the least studied. Today, the survival rate is 3% for five years. Professor Petersen, at the School of Biosciences at Cardiff University, hopes his team's research can change that.
› Verified 1 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists
Psychologists